Water Island Capital’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-2,347,489
Closed -$42.2M 124
2020
Q2
$42.2M Buy
+2,347,489
New +$32.7M 3.88% 10

Water Island Capital's PTLA Position: Q3 2020 in Review

Water Island Capital sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 2,347,489 shares — an estimated $42.2M sold.

Water Island Capital first reported a position in PTLA in Q2 2020 and held it in 1 quarter. The position peaked at $42.2M in Q2 2020. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

  • Water Island Capital reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Water Island Capital sold 2,347,489 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $42.2M.
  • Water Island Capital first reported a position in Portola Pharmaceuticals, Inc. in Q2 2020 and held it in 1 quarter.
  • Water Island Capital's Portola Pharmaceuticals, Inc. position peaked at $42.2M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Water Island Capital's 13F filing for Q3 2020, filed 12 Nov 2020.